Literature DB >> 21249413

A case of usual (basaloid)-type vulvar intraepithelial neoplasia that failed to respond to imiquimod cream: clinical implications.

Takaya Shiozaki1, Tsutomu Tabata, Kuniaki Toriyabe, Takashi Motohashi, Eiji Kondo, Kouji Tanida, Toshiharu Okugawa, Norimasa Sagawa.   

Abstract

The authors report a case of usual-type (basaloid-type) vulvar intraepithelial neoplasia (VIN) 3 that failed to respond to imiquimod cream. A 51-year-old Japanese woman visited her local gynecologist complaining of vulvar itching. Atypical cells were noted in cytology smears, but nine vulvar biopsy specimens showed benign proliferation of epithelial tissue. The patient was placed under careful observation for 8 months, when the vulvar smears once again showed atypical cells and biopsy specimens revealed VIN3. The patient was then referred to our hospital where she was given a diagnosis of VIN 3, basaloid type of usual type. The biopsy specimens were positive for p16 and the lesions were confirmed to be human papilloma virus (HPV)-related. We recommended simple vulvectomy but the patient requested conservative treatment with imiquimod cream. With her written informed consent, we prescribed imiquimod cream to be self-administered 3 times a week. Colposcopy and pap smear test were performed every 2 weeks. Four weeks after the start of treatment, a fingertip-sized papule was detected at the patient's vaginal introitus. By 6 weeks, the lesion had enlarged, and biopsy specimens revealed invasive squamous cell carcinoma. At 7 weeks, we performed simple vulvectomy. The surgical specimen showed stage pT1b keratinizing-type squamous cell carcinoma. HPV-16 DNA was detected in the specimen.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21249413     DOI: 10.1007/s10147-010-0180-4

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  7 in total

1.  p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias.

Authors:  Sabine Riethdorf; Eduardo F Neffen; Aida Cviko; Thomas Löning; Christopher P Crum; Lutz Riethdorf
Journal:  Hum Pathol       Date:  2004-12       Impact factor: 3.466

Review 2.  Epidemiology, diagnosis and treatment of vulvar intraepithelial neoplasia.

Authors:  Elmar A Joura
Journal:  Curr Opin Obstet Gynecol       Date:  2002-02       Impact factor: 1.927

3.  Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee.

Authors:  Mario Sideri; Ronald W Jones; Edward J Wilkinson; Mario Preti; Debra S Heller; James Scurry; Hope Haefner; Sallie Neill
Journal:  J Reprod Med       Date:  2005-11       Impact factor: 0.142

4.  Frequency of invasive cancer in surgically excised vulvar lesions with intraepithelial neoplasia (VIN 3).

Authors:  N Husseinzadeh; C Recinto
Journal:  Gynecol Oncol       Date:  1999-04       Impact factor: 5.482

5.  Imiquimod-induced clearance of HPV is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia.

Authors:  Annelinde Terlou; Manon van Seters; Alex Kleinjan; Claudia Heijmans-Antonissen; Lindy A M Santegoets; Ilse Beckmann; Marc van Beurden; Theo J M Helmerhorst; Leen J Blok
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

6.  Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women.

Authors:  Ronald W Jones; Darion M Rowan; Alistair W Stewart
Journal:  Obstet Gynecol       Date:  2005-12       Impact factor: 7.661

7.  Treatment of vulvar intraepithelial neoplasia with topical imiquimod.

Authors:  Manon van Seters; Marc van Beurden; Fiebo J W ten Kate; Ilse Beckmann; Patricia C Ewing; Marinus J C Eijkemans; Marjolein J Kagie; Chris J M Meijer; Neil K Aaronson; Alex Kleinjan; Claudia Heijmans-Antonissen; Freek J Zijlstra; Matthé P M Burger; Theo J M Helmerhorst
Journal:  N Engl J Med       Date:  2008-04-03       Impact factor: 91.245

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.